Ad
BPMC Quote Trading Chart Blueprint Medicines Corporation
home / stock / bpmc / bpmc quote
$70.46 Last:
34.85% Change Percent:
$70.83 Open:
$52.25 Previous Close:
$72.83 High:
$68.83 Low:
176,109 Volume:
12/31/1969 07:00:00 pm Last Trade Date Time:
Quotes are delayed by 15 to 20 minutes.
BPMC Last Five Trading Days
| Stock Date | Open Price | Close Price | High | Low | Volume |
|---|---|---|---|---|---|
| 2022-08-15 | 70.83 | 52.25 | 72.83 | 68.83 | 176,109 |
| 2022-08-12 | 70.24 | 52.25 | 73.03 | 70.1335 | 795,017 |
| 2022-08-11 | 71.15 | 52.25 | 71.875 | 69.09 | 973,618 |
| 2022-08-10 | 70.47 | 52.25 | 71.1 | 68.86 | 507,858 |
| 2022-08-09 | 69.72 | 52.25 | 71.1 | 67.6 | 1,262,502 |
| 2022-08-08 | 68.74 | 52.25 | 71.225 | 68.64 | 1,078,224 |
| 2022-08-05 | 63.87 | 52.25 | 69.81 | 63.07 | 1,233,492 |
| 2022-08-04 | 60.44 | 52.25 | 64.725 | 60 | 779,704 |
| 2022-08-03 | 57.76 | 52.25 | 59.72 | 57.76 | 744,398 |
| 2022-08-02 | 50 | 52.25 | 58.58 | 50 | 1,253,952 |
| 2022-08-01 | 50.58 | 52.25 | 52 | 50.1 | 460,300 |
| 2022-07-29 | 52.18 | 52.25 | 52.18 | 50.15 | 387,357 |
| 2022-07-28 | 52.25 | 52.25 | 52.975 | 50.19 | 405,092 |
| 2022-07-26 | 50.86 | 50.86 | 51.56 | 49.76 | 178,263 |
| 2022-07-25 | 52.23 | 51.04 | 52.23 | 49.91 | 538,697 |
| 2022-07-19 | 53.42 | 55.52 | 56.28 | 52.88 | 676,857 |
| 2022-07-18 | 54.3 | 52.46 | 54.95 | 51.59 | 945,038 |
| 2022-07-15 | 53.86 | 53.55 | 53.86 | 51.5 | 726,011 |
| 2022-07-14 | 54.91 | 52.22 | 54.91 | 51.76 | 569,644 |
| 2022-07-13 | 53.62 | 55.4 | 57.385 | 53.495 | 773,096 |
Blueprint Medicines Corporation Company Name:
BPMC Stock Symbol:
NASDAQ Market:
Blueprint Medicines Corporation Website:
News, Short Squeeze, Breakout and More Instantly...
Ad
-
Blueprint Medicines Reports Second Quarter 2022 Results PR Newswire -- Achieved $36.5 million in total revenues, including $28.5 million in AYVAKIT® (avapritinib) net product revenues representing 20 percent AYVAKIT revenue growth from Q1 2022 -- -- ...
-
Blueprint Medicines to Report Second Quarter 2022 Financial Results on Tuesday, August 2, 2022 PR Newswire CAMBRIDGE, Mass. , July 26, 2022 /PRNewswire/ -- Blueprint Medicines Corporation (NASDAQ: BPMC) today announced that it will host a live conference ...
-
Blueprint Medicines Publishes Inaugural Corporate Responsibility Report PR Newswire -- Report highlights efforts to deliver sustainable value to patients and communities, foster a diverse and empowered workforce, and operate with exceptional integrity -- CAMB...